328 Comparison of 48 or 72 weeks of treatment with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C infected with HCV genotype 1

Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2009.01157.x ◽

2010 ◽

Vol 17 (2) ◽

pp. 139-147 ◽

Cited By ~ 22

Author(s):

M. Rodriguez-Torres ◽

M. S. Sulkowski ◽

R. T. Chung ◽

F. M. Hamzeh ◽

D. M. Jensen

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virologic Response ◽

Genotype 1 ◽

Early Virologic Response ◽

Hcv Genotype ◽

Factors Associated ◽

Hcv Genotype 1 ◽

332 Peginterferon alfa-2A (40KD) (PEGASYS®) in combination with ribavirin in African American and Caucasian patients with chronic hepatitis C HCV genotype 1: safety and tolerability

Hepatology ◽

10.1016/s0270-9139(03)80375-0 ◽

2003 ◽

Vol 38 ◽

pp. 319-319 ◽

Cited By ~ 1

Author(s):

C HOWELL ◽

L JEFFERS ◽

W CASSIDY ◽

K RAJENDERREDDY ◽

S SHERIDAN ◽

...

Keyword(s):

African American ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Hcv Genotype ◽

Caucasian Patients ◽

Hcv Genotype 1 ◽

P1167 rs12979860 IL28B GENOTYPE IS ASSOCIATED WITH ADVANCED FIBROSIS IN HCV GENOTYPE 1-INFECTED EUROPEAN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS FROM THE INTERNATIONAL GEN-C STUDY

10.1016/s0168-8278(14)61327-1 ◽

2014 ◽

Vol 60 (1) ◽

pp. S473

Author(s):

A. Mangia ◽

V. De Ledinghen ◽

F. Bailly ◽

J. Brahm ◽

J. Keiss ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Il28b Genotype ◽

Advanced Fibrosis ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1

1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

10.1016/s0168-8278(12)61175-1 ◽

2012 ◽

Vol 56 ◽

pp. S460 ◽

Cited By ~ 4

Author(s):

H. Tatum ◽

P. Thuluvath ◽

E. Lawitz ◽

C.T. Martorell ◽

M. Demicco ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Hepatitis C Infection ◽

Ns5b Polymerase Inhibitor ◽

Treatment Naïve ◽

Polymerase Inhibitor ◽

Peginterferon Alfa ◽

Ns5b Polymerase

Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C

10.1016/j.jhep.2009.01.017 ◽

2009 ◽

Vol 51 (1) ◽

pp. 21-28 ◽

Cited By ~ 20

Author(s):

Avidan U. Neumann ◽

Stephen Pianko ◽

Stefan Zeuzem ◽

Eric M. Yoshida ◽

Yves Benhamou ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Sustained Virologic Response ◽

Virologic Response ◽

Genotype 1 ◽

Negative Prediction ◽

Treatment Naïve ◽

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

Journal of Viral Hepatitis ◽

10.1111/jvh.12289 ◽

2014 ◽

Vol 22 (3) ◽

pp. 254-262 ◽

Cited By ~ 6

Author(s):

T. Oze ◽

N. Hiramatsu ◽

T. Yakushijin ◽

R. Yamada ◽

N. Harada ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Side Effects ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Genotype 1 ◽

Hcv Genotype ◽

The Real ◽

Hcv Genotype 1 ◽

Chronic Hepatitis C Patients

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection

10.1016/j.jhep.2005.09.015 ◽

2006 ◽

Vol 44 (2) ◽

pp. 275-282 ◽

Cited By ~ 47

Author(s):

Peter Ferenci ◽

Elisabeth Formann ◽

Hermann Laferl ◽

Michael Gschwantler ◽

Franz Hackl ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Study ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Naïve ◽

Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment

Gastroenterology ◽

10.1016/s0016-5085(13)63649-5 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-982-S-983

Author(s):

Gero Moog ◽

Stefan Mauss ◽

Dietrich Hueppe ◽

Ulrich Spengler ◽

Eckart Schott ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Interim Analysis ◽

Real Life ◽

Genotype 1 ◽

Life Conditions ◽

Treatment Naïve ◽

4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON™ (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C

10.1016/s0168-8278(09)60006-4 ◽

2009 ◽

Vol 50 ◽

pp. S4 ◽

Cited By ~ 49

Author(s):

P. Kwo ◽

E. Lawitz ◽

J. McCone ◽

E. Schiff ◽

J. Vierling ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase 2 ◽

Genotype 1 ◽

Phase 2 Study ◽

Treatment Naïve ◽

Long-Term Outcomes of Ledipasvir/Sofosbuvir (LDV/ SOF) for the Treatment of Chronic Hepatitis C Infected (HCV) Genotype 1 Patients in the UK

Value in Health ◽

10.1016/j.jval.2014.08.2507 ◽

2014 ◽

Vol 17 (7) ◽

pp. A675

Author(s):

I. Guerra ◽

L. Marie ◽

S. Cure

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Long Term Outcomes ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

The Uk